The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis

British Journal of Pharmacology

Volumn 169, Issue 1, 2013, Pages 197-212

  Zhou, Yajun ^a   Zhai, Xuguang ^a   Yan, Kunfeng ^a   Fan, Jiye ^b   Niu, Minghui ^a   Zhou, Qian ^a   Zhou, Yan ^a   Chen, Hongshan ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b Hebei Chemical Medicine Vocational Technology College   (China)

Author keywords

catenin; glycogen synthase kinase 3 ; hepatic stellate cell; leptin; liver fibrosis; sterol regulatory element binding protein 1c

Indexed keywords

BETA CATENIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; LEPTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; HORMONE INHIBITION; HORMONE RESPONSE; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SREBP 1C GENE; STELLATE CELL; UPREGULATION;

ANIMALS; BETA CATENIN; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; LEPTIN; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; ORPHAN NUCLEAR RECEPTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84876272648     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12114     Document Type: Article

References (54)

1. Abiola M, Favier M, Christodoulou-Vafeiadou E, Pichard AL, Martelly I, Guillet-Deniau I, (2009). Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS ONE 4: e8509.
2. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, et al. (2012). Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun 3: 735-746.
3. Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E, et al. (2005). Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 42: 1339-1348.
4. Arango NA, Szotek PP, Manganaro TF, Oliva E, Donahoe PK, Teixeira J, (2005). Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol 288: 276-283.
5. Bertolani C, Marra F, (2010). Role of adipocytokines in hepatic fibrosis. Curr Pharm Des 16: 1929-1940.
6. Bikkavilli RK, Malbon CC, (2009). Mitogen-activated protein kinases and Wnt/beta-catenin signaling: molecular conversations among signaling pathways. Commun Integr Biol 2: 46-49.
7. Bikkavilli RK, Feigin ME, Malbon CC, (2008). p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta. J Cell Sci 121: 3598-3607.
8. Brugmann SA, Goodnough LH, Gregorieff A, Leucht P, ten Berge D, Fuerer C, et al. (2007). Wnt signaling mediates regional specification in the vertebrate face. Development 134: 3283-3295.
9. Cao Q, Mak KM, Lieber CS, (2006). Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways. J Cell Biochem 97: 188-197.
10. Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, Crimi N, et al. (2008). TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res 57: 274-282.
11. Cassiman D, van Pelt J, De Vos R, Van Lommel F, Desmet V, Yap SH, et al. (1999). Synaptophysin: a marker for human and rat hepatic stellate cells. Am J Pathol 155: 1831-1839.
12. Caverzasio J, Manen D, (2007). Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells. Endocrinology 148: 5323-5330.
13. Chen G, Liang G, Ou J, Goldstein JL, Brown MS, (2004). Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A 101: 11245-11250.
14. Cheng JH, She H, Han YP, Wang J, Xiong S, Asahina K, et al. (2008). Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 294: G39-G49.
15. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A, (2009). Adipogenesis and WNT signalling. Trends Endocrinol Metab 20: 16-24.
16. Deng X, Cagen LM, Wilcox HG, Park EA, Raghow R, Elam MB, (2002). Regulation of the rat SREBP-1c promoter in primary rat hepatocytes. Biochem Biophys Res Commun 290: 256-262.
17. Elinav E, Ali M, Bruck R, Brazowski E, Phillips A, Shapira Y, et al. (2009). Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function. Hepatology 49: 278-286.
18. Endo H, Hosono K, Uchiyama T, Sakai E, Sugiyama M, Takahashi H, et al. (2011). Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 60: 1363-1371.
19. Garza JC, Guo M, Zhang W, Lu XY, (2012). Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3β/β-catenin signaling. Mol Psychiatry 17: 790-808.
20. Goldstein JL, DeBose-Boyd RA, Brown MS, (2006). Protein sensors for membrane sterols. Cell 124: 35-46.
21. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS, (1997). Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 185: 82-91.
22. Hernandez-Gea V, Friedman SL, (2011). Pathogenesis of liver fibrosis. Annu Rev Pathol 6: 425-456.
23. Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, et al. (2002). Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 36: 12-21.
24. Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, et al. (2009). Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614-620.
25. Kawada N, Ikeda K, Seki S, Kuroki T, (1999). Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture. J Hepatol 30: 1057-1064.
26. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
27. Königshoff M, Eickelberg O, (2010). WNT signaling in lung disease: a failure or a regeneration signal? Am J Respir Cell Mol Biol 42: 21-31.
28. Lam AP, Gottardi CJ, (2011). β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol 23: 562-567.
29. Lee YS, Lee HH, Park J, Yoo EJ, Glackin CA, Choi YI, et al. (2003). Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c. Nucleic Acids Res 31: 7165-7174.
30. Liuzzi A, Savia G, Tagliaferri M, Berselli ME, Petroni ML, De Medici C, et al. (1999). Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord 23: 1066-1073.
31. McCullough AJ, Falck-Ytter Y, (1999). Body composition and hepatic steatosis as precursors for fibrotic liver disease. Hepatology 29: 1328-1329.
32. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
33. MacDonald BT, Tamai K, He X, (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
34. Ohba S, Lanigan TM, Roessler BJ, (2010). Leptin receptor JAK2/STAT3 signaling modulates expression of Frizzled receptors in articular chondrocytes. Osteoarthritis Cartilage 18: 1620-1629.
35. Potter JJ, Womack L, Mezey E, Anania FA, (1998). Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 244: 178-182.
36. Rangwala SM, Lazar MA, (2000). Transcriptional control of adipogenesis. Annu Rev Nutr 20: 535-559.
37. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. (2000). Liver fibrosis in overweight patients. Gastroenterology 118: 1117-1123.
38. Reynaert H, Rombouts K, Jia Y, Urbain D, Chatterjee N, Uyama N, et al. (2005). Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells. Br J Pharmacol 146: 77-88.
39. Rodionova E, Conzelmann M, Maraskovsky E, Hess M, Kirsch M, Giese T, et al. (2007). GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood 109: 1584-1592.
40. Sato R, (2010). Sterol metabolism and SREBP activation. Arch Biochem Biophys 501: 177-181.
41. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA, (2002). Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 35: 762-771.
42. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW, (2000). Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 285: 194-204.
43. She H, Xiong S, Hazra S, Tsukamoto H, (2005). Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem 280: 4959-4967.
44. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS, (1997). Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99: 838-845.
45. Stefanovic A, Kotur-Stevuljevic J, Spasic S, Bogavac-Stanojevic N, Bujisic N, (2008). The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients. Diabetes Res Clin Pract 79: 156-163.
46. Tsukamoto H, (2005). Adipogenic phenotype of hepatic stellate cells. Alcohol Clin Exp Res 29: 132S-133S.
47. Uno S, Endo K, Jeong Y, Kawana K, Miyachi H, Hashimoto Y, et al. (2009). Suppression of beta-catenin signaling by liver X receptor ligands. Biochem Pharmacol 77: 186-195.
48. Valenta T, Hausmann G, Basler K, (2012). The many faces and functions of β-catenin. EMBO J 31: 2714-2736.
49. Watanabe S, Yaginuma R, Ikejima K, Miyazaki A, (2008). Liver diseases and metabolic syndrome. J Gastroenterol 43: 509-518.
50. Yan K, Deng X, Zhai X, Zhou M, Jia X, Luo L, et al. (2012). p38 MAPK and LXRα mediate leptin effect on SREBP-1c expression in hepatic stellate cells. Mol Med 18: 10-18.
51. Yokaichiya DK, Galembeck E, Torres BB, Da Silva JA, de, Araujo DR, (2008). Insulin and leptin relations in obesity: a multimedia approach. Adv Physiol Educ 32: 231-236.
52. Zhou YT, Wang ZW, Higa M, Newgard CB, Unger RH, (1999). Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci U S A 96: 2391-2395.
53. Zhou Y, Jia X, Wang G, Wang X, Liu J, (2009). PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARgamma gene expression in primary rat hepatic stellate cells. Mol Cell Biochem 325: 131-139.
54. Zhou Y, Jia X, Qin J, Lu C, Zhu H, Li X, et al. (2010). Leptin inhibits PPARgamma gene expression in hepatic stellate cells in the mouse model of liver damage. Mol Cell Endocrinol 323: 193-200.